Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian Cancer

This publication has 12 references indexed in Scilit:

• A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment
  Gynecologic Oncology, 1998
• Phase I/II Study of Intraperitoneal Floxuridine and Platinums (Cisplatin and/or Carboplatin)
  Gynecologic Oncology, 1997
• Pharmacokinetic Problems in Peritoneal Drug Administration: Tissue Penetration and Surface Exposure
  JNCI: Journal of the National Cancer Institute, 1997
• Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
  New England Journal of Medicine, 1996
• Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy—A Randomized Phase II Study by the Southwest Oncology Group
  Gynecologic Oncology, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Intraperitoneal Administration of Cisplatin and 5-Fluorouracil in Residual Ovarian Cancer: A Phase II Gynecologic Oncology Group Trial
  Gynecologic Oncology, 1995
• Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer.
  Journal of Clinical Oncology, 1991
• Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.
  Journal of Clinical Oncology, 1990
• Microscopic disease at second-look laparotomy in advanced ovarian cancer
  Cancer, 1985